drugset / Trial / NCT05473468
Single Dose Study To Study The Absorption, Metabolism And Excretion Of Famitinib
NaSingle-groupOpen-labelBasic science
Summary
The purpose of this study is to evaluate the excretion balance, metabolic profile and the routes of excretion of famitinib in healthy adult male subjects.
Timeline
- Start
- 2022-08-26
- Primary completion
- 2022-11
- Completion
- 2022-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Famitinib | Small molecule | 25 mg | Oral |
Indications
No indication recorded.